Literature DB >> 677857

Cerebrospinal fluid penetration of amikacin.

D J Briedis, H G Robson.   

Abstract

Adult volunteers underwent a single lumbar puncture 1 to 8.5 h after one 7.5-mg/kg intramuscular amikacin injection. Eighteen showed no detectable drug in cerebrospinal fluid; six had concentrations <0.5 mug/ml.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 677857      PMCID： PMC352386          DOI： 10.1128/AAC.13.6.1042

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

Review 1.  Gram-negative bacillary meningitis.

Authors:  R J Mangi; R Quintiliani; V T Andriole
Journal:  Am J Med       Date:  1975-12       Impact factor: 4.965

Review 2.  Treatment of gram-negative bacillary meningitis in adults.

Authors:  J J Rahal
Journal:  Ann Intern Med       Date:  1972-08       Impact factor: 25.391

3.  Penetration of antibiotics into the cerebro-spinal fluid in inflammatory conditions. 3. Gentamicin.

Authors:  V Vacek; M Hejzlar; M Skálová
Journal:  Int Z Klin Pharmakol Ther Toxikol       Date:  1969-07

4.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

5.  Aminoglycoside therapy of gram-negative bacillary meningitis.

Authors:  A B Kaiser; Z A McGee
Journal:  N Engl J Med       Date:  1975-12-11       Impact factor: 91.245

6.  Hospital-acquired bacterial meningitis in neurosurgical patients.

Authors:  F J Buckwold; R Hand; R R Hansebout
Journal:  J Neurosurg       Date:  1977-04       Impact factor: 5.115

7.  Comparative pharmacokinetics of amikacin and kanamycin.

Authors:  J T Clarke; R D Libke; C Regamey; W M Kirby
Journal:  Clin Pharmacol Ther       Date:  1974-06       Impact factor: 6.875

8.  Gram-negative bacillary endocarditis. Interpretation of the serum bactericial test.

Authors:  C S Bryan; S R Marney; R H Alford; R E Bryant
Journal:  Am J Med       Date:  1975-02       Impact factor: 4.965

9.  Penetration of parenterally administered gentamicin into the cerebrospinal fluid in experimental meningitis.

Authors:  K Goitein; J Michel; T Sacks
Journal:  Chemotherapy       Date:  1975       Impact factor: 2.544

10.  Amikacin therapy for serious gram-negative bacillary infections.

Authors:  R D Meyer; R P Lewis; E D Carmalt; S M Finegold
Journal:  Ann Intern Med       Date:  1975-12       Impact factor: 25.391
  10 in total
  5 in total

1.  Cerebrospinal fluid compartmental pharmacokinetics of amikacin in neonates.

Authors:  K Allegaert; I Scheers; E Adams; G Brajanoski; V Cossey; B J Anderson
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191

Review 2.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

Review 3.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

4.  Intraventricular levels of amikacin after intravenous administration.

Authors:  R Yogev; W M Kolling
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

Review 5.  Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.

Authors:  Christopher A Darlow; Renata M A da Costa; Sally Ellis; François Franceschi; Mike Sharland; Laura Piddock; Shampa Das; William Hope
Journal:  Paediatr Drugs       Date:  2021-08-26       Impact factor: 3.022
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.